TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.050
-0.010 (-0.94%)
At close: Apr 10, 2026, 4:00 PM EDT
1.030
-0.020 (-1.90%)
After-hours: Apr 10, 2026, 7:29 PM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $63.11 million as of April 10, 2026. Its market cap has decreased by -23.09% in one year.
Market Cap
63.11M
Enterprise Value
4.84M
1-Year Change
-23.09%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $63.11M, a decrease of -82.43%. That is a compound annual growth rate of -30.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 63.11M | 11.20% |
| Dec 31, 2025 | 56.75M | -66.96% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | 359.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuCell | 64.01M |
| Entera Bio | 61.53M |
| Acrivon Therapeutics | 60.44M |
| PDS Biotechnology | 60.28M |
| OnKure Therapeutics | 58.80M |
| Grace Therapeutics | 55.55M |
| Radiopharm Theranostics | 55.26M |
| Instil Bio | 55.00M |